Alembic reports 11 per cent growth in revenue for Q4 FY22 from Rs 1,280 crores in FY21 to Rs 1,416…
Company recommended dividend of Rs 10 per equity share i.e. 500 per cent
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
IIT Mandi discovers molecule that might help in treating type-I and type-II diabetes
Researchers found that the molecule PK2 not only increases insulin release, but also prevents and reverses beta cell loss, making…
Avantor Foundation launches STEM Programming for Indian students
The initiative will include 15 schools in Thane district of Maharashtra impacting 3,000 students and 48 teachers
Biocon Q4FY22 revenue at Rs 2,476 crores, up 21 per cent
FY22 revenue at Rs 8,397 crores, up 14 per cent; core EBITDA up 18 per cent at Rs 2,669 crores; PBT (before Exceptional Item) at…
Taking India beyond ‘Pharmacy of the World’
A policy to incentivise pharma R&D is crucial as there are already signs that pharma R&D dives when revenues dip
Pharma exports hit Rs 1.83 lakh crores in FY2021-22
The exports in 2021-22 sustained a positive growth despite the global trade disruptions and drop in demand for COVID-related…
Chinese Omicron-specific mRNA COVID vaccine candidate to be trialled in UAE
With the announcement, Abogen joins Pfizer/BioNTech and Moderna in trialling candidates modified specifically against Omicron
AstraZeneca says its COVID shot has market potential despite lower demand
AstraZeneca has started earning a modest profit on the vaccine, which was initially sold at-cost. However, the British drugmaker…
Moderna to build COVID-19 vaccine facility in Canada
Construction is set to start this year and the facility is expected to be operational in 2024 at the earliest, subject to planning…
NTAGI panel recommends Covovax in vaccination drive for 12-17 years’ age group
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December last year and in…
GSK and SK bioscience’s COVID vaccine submitted for S Korea approval
GSK said that SK bioscience will also apply to WHO for EUL and seek authorisations at individual regulatory agencies around the…
Government to expedite process of recognition of Biological E Corbevax by other countries
According to an internal document circulated to the members of the Empowered Group-5 on COVID-19 Vaccination, which will be…
US FDA approves Bristol Myers’ oral heart disease drug
The company said the drug comes with a boxed warning for the risk of heart failure
Lupin launches regional reference laboratory in Guwahati
With this, the company expands its diagnostics business footprint in north-east India
Syngene reports full year revenue from operations up 19 per cent to Rs 2,604 crores
Revenue from operations up 15 per cent to Rs 758 crores in fourth quarter
People need to be at the centre of any business and cultural transformation
Vani Manja, Managing Director- Boehringer Ingelheim, India, speaks to Ashwini Prakash, Managing Partner, India and Singapore and…
Bharat Biotech must address WHO’s Covaxin supply suspension to avoid EUL cancellation, says…
In a communication to Dr V K Paul, Member (health), NITI Aayog, Ministry of External Affairs (MEA) said many issues about vaccines…
WHO-backed vaccine resolution wins 24 per cent support at Moderna
Proponents say production shifts could help combat the global pandemic
Pfizer to start US trial of gene therapy as FDA lifts hold
The FDA had put Pfizer's trial request on hold after the death of a patient in another early-stage study of the therapy for…
Thermo Fisher Scientific expands R&D facility in Hyderabad
KT Rama Rao, Minister for Industries and Commerce, Government of Telangana, inaugurated the facility